Susan Shiff

Susan Shiff

Chief Executive Officer at
Huma.AI, Inc.

Net worth: 10 102 $ as of 2026-08-30

65 year
Health Technology
Consumer Services
Technology Services

Profile

Susan Patricia Shiff is currently Chief Executive Officer & Director at Huma.ai, Inc. since 2024.
She is a Director at Merck Global Health Innovation Fund LLC, Director at Synthace Ltd. since 2018, Independent Director at Tvardi Therapeutics, Inc. starting in 2025, and Trustee at New Jersey Symphony Orchestra.
Former roles include Independent Director at CARA Therapeutics, Inc., Senior Vice President at Merck & Co., Inc. from 2014 to 2021, Vice President at Pfizer Inc., Vice President-Global Health Economics at Teva Pharmaceutics, and President at Ontada LLC from 2021 to 2023.
Education includes a doctorate from the University of California, Los Angeles and an MBA from Cornell University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
0.04%
2026-06-08 5,612 ( 0.04% ) 10 102 $ 2026-08-30

Susan Shiff active positions

CompaniesPositionStart
Director/Board Member 2018-06-04
Director/Board Member -
Director/Board Member -
Chief Executive Officer 2024-06-30

Former positions of Susan Shiff

CompaniesPositionEnd
President 2023-06-30
MERCK & CO., INC. Corporate Officer/Principal 2021-02-28
PFIZER INC. Corporate Officer/Principal -
Teva Pharmaceutics
Corporate Officer/Principal -
CARA THERAPEUTICS, INC. Director/Board Member -
See the detail of Susan Shiff's experience

Training of Susan Shiff

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

78

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Teva Pharmaceutics

Finance

Technology Services

Technology Services

Health Services